Published in Trends Immunol on October 24, 2016
Human T cell development notched up a level. Nat Methods (2017) 0.75
Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell (2007) 101.42
Epigenetic memory in induced pluripotent stem cells. Nature (2010) 14.31
T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia. Sci Transl Med (2011) 12.58
Induction of T cell development from hematopoietic progenitor cells by delta-like-1 in vitro. Immunity (2002) 8.17
CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia. Sci Transl Med (2013) 7.99
Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias. Blood (2011) 7.49
Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans. Cell (1993) 6.83
Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells. Science (2010) 5.50
Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity. Proc Natl Acad Sci U S A (1989) 4.63
Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells. Nat Biotechnol (2011) 3.25
Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development. Science (1995) 3.15
Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID). Nature (1995) 2.93
Genome-wide characterization of the routes to pluripotency. Nature (2014) 2.34
Divergent reprogramming routes lead to alternative stem-cell states. Nature (2014) 2.31
Engineering CD19-specific T lymphocytes with interleukin-15 and a suicide gene to enhance their anti-lymphoma/leukemia effects and safety. Leukemia (2010) 2.22
Primary immunodeficiencies. J Allergy Clin Immunol (2009) 2.05
Wnt signaling controls the specification of definitive and primitive hematopoiesis from human pluripotent stem cells. Nat Biotechnol (2014) 2.05
An essential developmental checkpoint for production of the T cell lineage. Science (2010) 2.01
Generation of rejuvenated antigen-specific T cells by reprogramming to pluripotency and redifferentiation. Cell Stem Cell (2013) 2.01
Combined effects of Notch signaling and cytokines induce a multiple log increase in precursors with lymphoid and myeloid reconstituting ability. Blood (2002) 2.00
T lymphocyte potential marks the emergence of definitive hematopoietic progenitors in human pluripotent stem cell differentiation cultures. Cell Rep (2012) 1.99
Induction of T-cell development from human cord blood hematopoietic stem cells by Delta-like 1 in vitro. Blood (2004) 1.98
Differential effects of Notch ligands Delta-1 and Jagged-1 in human lymphoid differentiation. J Exp Med (2001) 1.94
An alternative pluripotent state confers interspecies chimaeric competency. Nature (2015) 1.90
Immunogenicity of somatic mutations in human gastrointestinal cancers. Science (2015) 1.87
Adoptive transfer of T-cell precursors enhances T-cell reconstitution after allogeneic hematopoietic stem cell transplantation. Nat Med (2006) 1.85
Development of alphabeta T cells in the human thymus. Nat Rev Immunol (2002) 1.83
Phase I/II Trial of StemRegenin-1 Expanded Umbilical Cord Blood Hematopoietic Stem Cells Supports Testing as a Stand-Alone Graft. Cell Stem Cell (2015) 1.82
Regeneration of human tumor antigen-specific T cells from iPSCs derived from mature CD8(+) T cells. Cell Stem Cell (2013) 1.79
Recognition of glioma stem cells by genetically modified T cells targeting EGFRvIII and development of adoptive cell therapy for glioma. Hum Gene Ther (2012) 1.75
Hierarchy of Notch-Delta interactions promoting T cell lineage commitment and maturation. J Exp Med (2007) 1.73
Efficient generation of human T cells from a tissue-engineered thymic organoid. Nat Biotechnol (2000) 1.72
Current advances in humanized mouse models. Cell Mol Immunol (2012) 1.65
Cord blood expansion. Pyrimidoindole derivatives are agonists of human hematopoietic stem cell self-renewal. Science (2014) 1.56
Lymphoid regeneration from gene-corrected SCID-X1 subject-derived iPSCs. Cell Stem Cell (2015) 1.52
Humanized mouse models to study human diseases. Curr Opin Endocrinol Diabetes Obes (2010) 1.48
Mimicking stem cell niches to increase stem cell expansion. Curr Opin Biotechnol (2008) 1.44
Reconstitution of the immune system after hematopoietic stem cell transplantation in humans. Semin Immunopathol (2008) 1.42
Generation of tumor-targeted human T lymphocytes from induced pluripotent stem cells for cancer therapy. Nat Biotechnol (2013) 1.39
Improving adoptive T cell therapy by targeting and controlling IL-12 expression to the tumor environment. Mol Ther (2011) 1.36
Cancer immunoediting: antigens, mechanisms, and implications to cancer immunotherapy. Ann N Y Acad Sci (2013) 1.34
IL-12 release by engineered T cells expressing chimeric antigen receptors can effectively Muster an antigen-independent macrophage response on tumor cells that have shut down tumor antigen expression. Cancer Res (2011) 1.33
Infectious morbidity in long-term survivors of allogeneic marrow transplantation is associated with low CD4 T cell counts. Am J Hematol (1997) 1.27
Characterization in vitro and engraftment potential in vivo of human progenitor T cells generated from hematopoietic stem cells. Blood (2009) 1.22
An epigenomic roadmap to induced pluripotency reveals DNA methylation as a reprogramming modulator. Nat Commun (2014) 1.18
Human intrathymic lineage commitment is marked by differential CD7 expression: identification of CD7- lympho-myeloid thymic progenitors. Blood (2007) 1.12
Functional human antigen-specific T cells produced in vitro using retroviral T cell receptor transfer into hematopoietic progenitors. J Immunol (2007) 1.10
Building better chimeric antigen receptors for adoptive T cell therapy. Curr Gene Ther (2010) 1.10
Small RNA changes en route to distinct cellular states of induced pluripotency. Nat Commun (2014) 1.09
Differences in lymphocyte developmental potential between human embryonic stem cell and umbilical cord blood-derived hematopoietic progenitor cells. Blood (2008) 1.08
Human thymocyte development in mouse organ cultures. Int Immunol (1990) 1.04
Notch signaling during human T cell development. Curr Top Microbiol Immunol (2012) 1.02
Costimulation by chimeric antigen receptors revisited the T cell antitumor response benefits from combined CD28-OX40 signalling. Int J Cancer (2011) 1.01
Proteome adaptation in cell reprogramming proceeds via distinct transcriptional networks. Nat Commun (2014) 1.00
Advances in umbilical cord blood manipulation-from niche to bedside. Nat Rev Clin Oncol (2014) 0.99
Functionally mature CD4 and CD8 TCRalphabeta cells are generated in OP9-DL1 cultures from human CD34+ hematopoietic cells. J Immunol (2009) 0.98
Dynamics of thymus-colonizing cells during human development. Immunity (2006) 0.96
Dynamics of thymus organogenesis and colonization in early human development. Development (2013) 0.94
Human proT-cells generated in vitro facilitate hematopoietic stem cell-derived T-lymphopoiesis in vivo and restore thymic architecture. Blood (2013) 0.94
New cell sources for T cell engineering and adoptive immunotherapy. Cell Stem Cell (2015) 0.93
T-lymphoid differentiation potential measured in vitro is higher in CD34+CD38-/lo hematopoietic stem cells from umbilical cord blood than from bone marrow and is an intrinsic property of the cells. Haematologica (2011) 0.93
Expansion and homing of umbilical cord blood hematopoietic stem and progenitor cells for clinical transplantation. Biol Blood Marrow Transplant (2014) 0.92
Biomaterial-based notch signaling for the differentiation of hematopoietic stem cells into T cells. J Biomed Mater Res A (2006) 0.91
In vitro intrathymic differentiation kinetics of human fetal liver CD34+CD38- progenitors reveals a phenotypically defined dendritic/T-NK precursor split. J Immunol (1999) 0.88
Human CD8 T cells generated in vitro from hematopoietic stem cells are functionally mature. BMC Immunol (2011) 0.87
Diverse T-cell differentiation potentials of human fetal thymus, fetal liver, cord blood and adult bone marrow CD34 cells on lentiviral Delta-like-1-modified mouse stromal cells. Immunology (2008) 0.86
Human bone marrow and umbilical cord blood cells generate CD4+ and CD8+ single-positive T cells in murine fetal thymus organ culture. Proc Natl Acad Sci U S A (1993) 0.86
CD45RA depletion in HLA-mismatched allogeneic hematopoietic stem cell transplantation for primary combined immunodeficiency: A preliminary study. J Allergy Clin Immunol (2014) 0.85
CD45 isoform switching precedes the activation-driven death of human thymocytes by apoptosis. Int Immunol (1991) 0.85
Human T-lymphoid progenitors generated in a feeder-cell-free Delta-like-4 culture system promote T-cell reconstitution in NOD/SCID/γc(-/-) mice. Stem Cells (2012) 0.84
Modeling Human Severe Combined Immunodeficiency and Correction by CRISPR/Cas9-Enhanced Gene Targeting. Cell Rep (2015) 0.83
Identification of human T-lymphoid progenitor cells in CD34+ CD38low and CD34+ CD38+ subsets of human cord blood and bone marrow cells using NOD-SCID fetal thymus organ cultures. Br J Haematol (1999) 0.83
Induction of T-cell development by Delta-like 4-expressing fibroblasts. Int Immunol (2013) 0.83
Generation of functional, antigen-specific CD8+ human T cells from cord blood stem cells using exogenous Notch and tetramer-TCR signaling. Stem Cells (2014) 0.82
Directed differentiation of definitive hemogenic endothelium and hematopoietic progenitors from human pluripotent stem cells. Methods (2015) 0.81
Broad T-cell receptor repertoire in T-lymphocytes derived from human induced pluripotent stem cells. PLoS One (2014) 0.81
Human adenovirus-specific γ/δ and CD8+ T cells generated by T-cell receptor transfection to treat adenovirus infection after allogeneic stem cell transplantation. PLoS One (2014) 0.79
Expansion of Tumor-reactive T Cells From Patients With Pancreatic Cancer. J Immunother (2016) 0.78
Reprogramming of Melanoma Tumor-Infiltrating Lymphocytes to Induced Pluripotent Stem Cells. Stem Cells Int (2015) 0.77
Modeling altered T-cell development with induced pluripotent stem cells from patients with RAG1-dependent immune deficiencies. Blood (2016) 0.77
Enhancing the efficacy of engraftment of cord blood for hematopoietic cell transplantation. Transfus Apher Sci (2016) 0.76
Engineering approaches for regeneration of T lymphopoiesis. Biomater Res (2016) 0.76
Embryonic stem cells make human T cells. Proc Natl Acad Sci U S A (2006) 0.76
Simple and efficient generation of virus-specific T cells for adoptive therapy using anti-4-1BB antibody. J Immunother (2015) 0.76
Generation of tumor-specific cytotoxic T-lymphocytes from the peripheral blood of colorectal cancer patients for adoptive T-cell transfer. J Cell Physiol (2015) 0.76
Induced Pluripotent Stem Cell as a New Source for Cancer Immunotherapy. Genet Res Int (2016) 0.76